M-CERSI Workshop Spotlights 3D Cell Culture Models for Drug PK, Safety, and Efficacy Assessment
September 30, 2020
The U.S. Food and Drug Administration (FDA) and the University of Maryland Center for Excellence in Regulatory Science and Innovation (M-CERSI) co-hosted the virtual “3D Cell Culture Models for Drug PK, Safety, and Efficacy Assessment” workshop on Aug. 14. The meeting drew 360 attendees, including stakeholders from the FDA, academia, and industry, as well as participants around the world. Read more: http://news.pharmacy.umaryland.edu/m-cersi-workshop-spotlights-3d-cell-culture-models-for-drug-pk-safety-and-efficacy-assessment/.